PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

International radiology consensus outlines best practices for post-COVID CT

2025-07-22
(Press-News.org) OAK BROOK, Ill. – Experts representing multiple societies and institutions across 14 countries have published guidance for computed tomography (CT) imaging in patients with residual lung abnormalities after COVID-19 illness. The consensus statement appears today in Radiology, a journal of the Radiological Society of North America (RSNA).

The statement’s authors seek to standardize the indications for when chest CT is appropriate for patients with post–COVID-19 condition, the methods for acquiring images and the terminology used for reporting residual lung abnormalities. The final consensus was reviewed by four expert pulmonologists to ensure alignment with clinical perspectives.

Using standardized and specific terminology when reporting these abnormalities helps to avoid confusion with interstitial lung diseases (ILDs), explained statement coauthor Anna Rita Larici, M.D., an associate professor of radiology at Catholic University of the Sacred Heart of Rome and chief of the Chest Imaging Unit at Advanced Radiology Center of Agostino Gemelli University Polyclinic Foundation in Rome, Italy. It also helps physicians make more informed decisions about patient management, and it captures more precise data for future research.

“These statements recommend employing terms from the Fleischner Society Glossary to describe CT findings consistently and precisely, avoiding the use of ‘interstitial lung abnormality (ILA),’ which refers to a different clinical context,” Dr. Larici said. “In addition, we have coined and recommended the term ‘post–COVID-19 residual lung abnormality’ to prevent any misleading term when describing CT lung abnormalities following COVID-19 pneumonia.”

The authors also outlined the conditions under which chest CT imaging is appropriate for this patient group. They recommend chest CT for patients whose respiratory symptoms continue or worsen three months after infection, with these symptoms lasting for at least two months and with no other explanation. A chest CT scan three to six months after discharge may also be considered for all patients hospitalized with moderate to severe COVID-19 due to the high rate of residual CT lung abnormalities observed in these patients.

The group suggests that follow-up be guided by radiological expertise in conjunction with clinical judgment, considering its frequency based on the extent of initial lung abnormalities, temporal changes and/or pulmonary physiology.

Radiologists should adhere to the “as low as reasonably achievable” (ALARA) principle for serial CT follow-up, using a low-dose protocol within a range of 1 to 3 millisieverts, the authors advised.

“Radiologists play a crucial role in adhering to ALARA principles by optimizing CT protocols—using appropriate low-dose techniques during follow-ups—while maintaining the image quality necessary for accurate assessment,” Dr. Larici said. “This is especially important when serial imaging of these patients is needed, so that we minimize radiation exposure without compromising diagnostic accuracy.”

COVID-19 can cause continuing or worsening symptoms after infection—described as post–COVID-19 condition or “long COVID”—and approximately 6% of individuals who have had COVID-19 are estimated to experience post–COVID-19 condition. Among patients hospitalized for acute COVID-19, on average, 50% show chest CT abnormalities, and 25% have restrictive pulmonary functional abnormalities at four months after infection. Radiologists face several unique challenges when caring for this patient population.

“These include differentiating between persistent residual COVID-19 lung abnormalities and evolving fibrotic changes, interpreting overlapping features such as ground-glass opacities versus fibrosis, and assessing the temporal evolution of these findings,” Dr. Larici explained. “Distinguishing post–COVID-19 residual lung abnormalities from ILA and ILDs is crucial, because they have very different clinical implications: post–COVID-19 changes typically stabilize over time, whereas ILA and ILDs can progress.”

It’s important to understand that post–COVID-19 lung abnormalities can persist for months and potentially impact respiratory health, she said.

“Follow-up imaging plays a key role in assessing these residual changes and guiding clinical care, but it should be performed judiciously. Adherence to established recommendations helps ensure that patients receive follow-up imaging and care only when clinically indicated,” Dr. Larici said.

Dr. Larici noted that being part of a global team of experts working together signifies a collective effort to establish evidence-based, harmonized best practices for caring for patients recovering from post–COVID-19 pneumonia.

“It reflects a commitment to advancing patient care worldwide through shared knowledge, research and consensus,” she said.

###

“Best Practice: International Multisociety Consensus Statement for Post–COVID-19 Residual Abnormalities on Chest CT Scans.” Collaborating with Dr. Larici were Soon Ho Yoon, M.D., Ph.D., Jeffrey P. Kanne, M.D., Kazuto Ashizawa, M.D., Ph.D., Jürgen Biederer, M.D., Eva Castañer, M.D., Ph.D., Li Fan, M.D., Thomas Frauenfelder, M.D., Benoit Ghaye, M.D., Ph.D., Travis S. Henry, M.D., Yu-Sen Huang, M.D., Ph.D., Yeon Joo Jeong, M.D., Ph.D., Fernando U. Kay, M.D., Ph.D., Seth Kligerman, M.D., Jane P. Ko, M.D., Anagha P. Parkar, M.D., Ph.D., Nitra Piyavisetpat, M.D., Helmut Prosch, M.D., Constantine A. Raptis, M.D., Scott Simpson, D.O., Nobuyuki Tanaka, M.D., Kevin K. Brown, M.D., Yoshikazu Inoue, M.D., Ph.D., Nathan Sandbo, M.D., and Luca Richeldi, M.D., Ph.D.

Radiology is edited by Linda Moy, M.D., New York University, New York, N.Y., and owned and published by the Radiological Society of North America, Inc. (https://pubs.rsna.org/journal/radiology)

RSNA is an association of radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Illinois. (RSNA.org)

For patient-friendly information on lung CT, visit RadiologyInfo.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

Yellowstone aspen showing signs of recovery following 1995 reintroduction of wolves to park

2025-07-22
CORVALLIS, Ore. – Yellowstone National Park is celebrating an ecological milestone along with a key anniversary this summer, Oregon State University researchers report. A paper published today in Forest Ecology and Management documents the first new generation of overstory aspen trees in Yellowstone’s northern range in 80 years, three decades after wolves were reintroduced to the nation’s oldest national park. Without predation pressure from wolves, which had been extirpated from the park by 1930, elk populations grew to the point that their browsing was thwarting the growth of young aspen. The ecosystem effects ...

Post-COVID-related lung abnormalities almost always regress

2025-07-22
Visible on chest CT scans, post-COVID-19 residual lung abnormalities, which affect up to 50% of patients who have had an infection requiring hospitalization, may be associated with persistent or progressive respiratory symptoms and are often related to changes in respiratory function tests. But unlike other non-infectious abnormalities, they tend to stabilize or regress over time, indicating that they are non-progressive and only post-infectious in nature. Published in the journal Radiology, the paper is the result of a multi-society consensus statement developed by 21 chest radiologists belonging to the European Society of Thoracic Imaging (ESTI), the Society ...

City of Hope research spotlight, June 2025

2025-07-22
LOS ANGELES — City of Hope® Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, life-threatening diseases. Each spotlight features research-related news, such as recognitions, collaborations and the latest research defining the future of medical treatment.  This roundup highlights a new drug combination that slows the spread of advanced prostate cancer, a novel artificial intelligence (AI) conversation ...

SwRI completes 8-year-long NEXTCAR energy efficiency project

2025-07-22
SAN ANTONIO — July 22, 2025 — Southwest Research Institute (SwRI) has successfully completed its ambitious eight-year-long connected and automated (CAV) vehicle technology project. As part of the Advanced Research Projects Agency-Energy’s (ARPA-E) NEXTCAR (NEXT-Generation Energy Technologies for Connected and Automated On-Road Vehicles) program, SwRI developed an automated vehicle that combines CAV technology and SAE Level 4 automation to demonstrate up to 30% energy savings compared to traditional hybrid vehicles, without modifications to the powertrain hardware. The completed SwRI ...

Investigational anti-cancer DNA therapy eases chronic osteoarthritis pain in dogs—pointing to a new non-opioid path for humans

2025-07-22
BOSTON: Elenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain demonstrating a 90% success rate. In a peer-reviewed study published in Frontiers in Veterinary Science (DOI: 10.3389/fvets.2025.1519881), Elenagen reduced osteoarthritis pain scores in companion dogs. Because the same pro-inflammatory cytokine loop drives osteoarthritis and other chronic pain states, the findings offer ...

US adolescents with cannabis use disorder failing to complete rehabilitation

2025-07-22
Cannabis use disorder in adolescents in the United States remains a growing threat despite declines in cannabis use. Many adolescents begin using cannabis before high school during crucial stages of brain development, which may pose short- and long-term risks for cognitive, academic and social challenges. Although behavioral therapies show promise, there is still limited understanding of what truly drives recovery in teens. With treatment often sought only after serious problems emerge, identifying who succeeds – and why – is essential to developing more effective and targeted ...

Researchers at Notre Dame detect ‘forever chemicals’ in reusable feminine hygiene products

2025-07-22
When a reporter with the Sierra Club magazine asked Graham Peaslee, a physicist at the University of Notre Dame, to test several different samples of unused menstrual underwear for per- and polyfluoroalkyl substances (PFAS) in 2019, the results fueled concern over chemical exposure in feminine hygiene products — which ultimately ended up in a $5 million lawsuit against the period and incontinence underwear brand Thinx. Then in 2023, the New York Times asked Peaslee to test 44 additional period and incontinence products for PFAS, a class of toxic fluorinated compounds inherently repellent to oil, water, soil and stains, and ...

Study finds “forever chemicals” in reusable feminine hygiene products

2025-07-22
BLOOMINGTON, INDIANA — A new study from researchers at the Indiana University Paul H. O’Neill School of Public and Environmental Affairs and the University of Notre Dame shows that per- and polyfluoroalkyl chemicals (PFAS)—also known as “forever chemicals”—can be found in reusable feminine hygiene products. The pilot study provides information that will be useful for consumers, regulators, and manufacturers. Published in Environmental Science & Technology Letters, the article, “Per- and polyfluoroalkyl substances in reusable ...

Four abstracts using Bronchiectasis and NTM Research Registry data presented at World Bronchiectasis Conference

2025-07-22
Miami (July 22, 2025) – The Bronchiectasis and NTM Association announced today that four abstracts using Bronchiectasis and NTM Research Registry data were presented at the World Bronchiectasis Conference, held July 14-17, 2025, in Brisbane, Australia. The abstracts are: “The Impact of Proton Pump Inhibitor (PPI) Use on Exacerbation Rates in Patients with Bronchiectasis: An Analysis of the US Bronchiectasis and NTM Research Registry,” which examined the impact proton pump inhibitor use has on exacerbation and hospital stay frequency and disease severity. “High frequency chest ...

Social steps to mitigate mental illness

2025-07-22
Mental illnesses are thought to be caused by both biological and environmental factors in complex interaction. Among the environmental contributors are a wide range of social, economic, and demographic factors known as “social determinants.” Adam Skinner and colleagues used dynamic Bayesian network analysis to infer the complex causal networks that link social determinants to mental health in a nationally representative sample, consisting of around 25,000 participants in the Household, Income and Labour Dynamics in Australia (HILDA) Survey. The authors identified variables that directly ...

LAST 30 PRESS RELEASES:

Expanded school-based program linked to lower youth tobacco use rates in California

TV depictions of Hands-Only CPR are often misleading

What TV gets wrong about CPR—and why it matters for saving lives

New study: How weight loss benefits the health of your fat tissue

Astronomers surprised by mysterious shock wave around dead star

‘Death by a thousand cuts’: Young galaxy ran out of fuel as black hole choked off supplies

Glow with the flow: Implanted 'living skin' lights up to signal health changes

Compressed data technique enables pangenomics at scale

How brain waves shape our sense of self

Whole-genome sequencing may optimize PARP inhibitor use

Like alcohol units, but for cannabis – experts define safer limits

DNA testing of colorectal polyps improves insight into hereditary risks

Researchers uncover axonal protein synthesis defect in ALS

Why are men more likely to develop multiple myeloma than women?

Smartphone-based interventions show promise for reducing alcohol and cannabis use: New research

How do health care professionals determine eligibility for MAiD?

Microplastics detected in rural woodland 

JULAC and Taylor & Francis sign open access agreement to boost the impact of Hong Kong research

Protecting older male athletes’ heart health 

KAIST proposes AI-driven strategy to solve long-standing mystery of gene function

Eye for trouble: Automated counting for chromosome issues under the microscope

The vast majority of US rivers lack any protections from human activities, new research finds

Ultrasound-responsive in situ antigen "nanocatchers" open a new paradigm for personalized tumor immunotherapy

Environmental “superbugs” in our rivers and soils: new one health review warns of growing antimicrobial resistance crisis

Triple threat in greenhouse farming: how heavy metals, microplastics, and antibiotic resistance genes unite to challenge sustainable food production

Earthworms turn manure into a powerful tool against antibiotic resistance

AI turns water into an early warning network for hidden biological pollutants

Hidden hotspots on “green” plastics: biodegradable and conventional plastics shape very different antibiotic resistance risks in river microbiomes

Engineered biochar enzyme system clears toxic phenolic acids and restores pepper seed germination in continuous cropping soils

Retail therapy fail? Online shopping linked to stress, says study

[Press-News.org] International radiology consensus outlines best practices for post-COVID CT